Centrus Energy Corp.
LEU
$173.89
+2.01%
Centrus Energy Corp. is a leading supplier of nuclear fuel and services for the nuclear power industry, operating through its Low-Enriched Uranium (LEU) and Technical Solutions segments. As the only U.S.-owned producer of High-Assay Low-Enriched Uranium (HALEU), a critical fuel for advanced reactors, Centrus holds a unique strategic position in the domestic nuclear supply chain. The company is currently at the center of the AI-driven nuclear energy boom, with a record $3.9 billion backlog and a $900 million government contract, but faces execution risks related to its Russian contract expiration and the scaling of its HALEU production.…
LEU
Centrus Energy Corp.
$173.89
Related headlines
Investment Opinion: Should I buy LEU Today?
Based on the analysis, I rate LEU a Hold. The consensus is a Buy with an average target of $253.25, implying 44% upside, but the extreme valuation and execution risks temper enthusiasm. The thesis is that Centrus is a strategic monopoly in HALEU with a massive backlog, but the current price already reflects much of this optimism, leaving limited margin of safety.
Sign up to view all
LEU 12-Month Price Forecast
The AI assessment is neutral with medium confidence. The company has a strong strategic position in HALEU, but the valuation is stretched and the financial performance is volatile. The key factor is whether the company can convert its backlog into consistent earnings growth. If revenue growth reaccelerates above 20% and free cash flow turns positive, the stance would upgrade to bullish. Conversely, if execution issues persist and the company needs to raise capital, the stance would downgrade to bearish.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Centrus Energy Corp.'s 12-month outlook, with a consensus price target around $253.25 and implied upside of +45.6% versus the current price.
Average Target
$253.25
0 analysts
Implied Upside
+45.6%
vs. current price
Analyst Count
—
covering this stock
Price Range
$180 - $340
Analyst target range
The analyst price targets range from a low of $180.00 to a high of $340.00, with the high target implying a 93.4% upside from the current price, reflecting optimism about the company's HALEU monopoly and the AI-driven nuclear demand. The low target of $180.00 is only 2.4% above the current price, suggesting that even the most bearish analyst sees limited downside, likely due to the company's strong backlog and government contracts. The wide spread between the low and high targets (160 points) indicates significant uncertainty about the pace of HALEU commercialization and the resolution of the Russian contract expiration, but the overall consensus leans bullish, with the average target well above the current price.
Drowning in data?
Find the real signal!
Bulls vs Bears: LEU Investment Factors
Centrus Energy presents a classic high-risk, high-reward opportunity. The bull case is anchored by its monopoly in HALEU, record backlog, and strong analyst support, while the bear case highlights extreme valuation, revenue lumpiness, and execution risks. Currently, the bearish evidence is slightly stronger due to the stock's poor price performance and negative cash flow, but the potential for HALEU commercialization could quickly shift the balance. The most important tension is whether the company can successfully scale HALEU production and convert its backlog into consistent, growing earnings, which would justify the premium valuation. If it fails, the stock could fall to the 52-week low of $142.13, a 19% downside; if it succeeds, it could reach the analyst high target of $340, a 93% upside.
Bullish
- Monopoly in U.S. HALEU production: Centrus is the only U.S.-owned producer of HALEU, a critical fuel for advanced reactors. This unique position is reinforced by a $900 million government contract and a record $3.9 billion backlog, providing multi-year revenue visibility.
- Record backlog and government support: The $3.9 billion backlog and $900 million government contract underpin future revenue. The recent long-term fuel supply agreement with Oklo (June 2026) further validates demand and locks in revenue, directly addressing a key bottleneck in the advanced nuclear sector.
- Analyst consensus is Buy with high upside: With 16 analysts, the consensus rating is 'Buy' (mean 1.78) and the average target price is $253.25, implying ~44% upside from the current price of $175.78. The high target of $340 suggests 93% upside, reflecting strong optimism about HALEU commercialization.
- Improving profitability and strong margins: The trailing twelve-month net margin is 17.3%, and the latest quarter (Q1 2026) showed a gross margin of 38.7%, up from 23.9% in Q4 2025. The company is profitable with TTM net income of $10 million, and forward PE of 45.98x implies expected earnings growth of ~18%.
Bearish
- Extreme valuation multiples: The trailing PE is 56.06x and forward PE is 45.98x, far above the market average. Even with expected growth, the PEG ratio is negative (-15.73) due to volatile earnings, indicating the stock is priced for perfection and vulnerable to multiple compression.
- Revenue volatility and lumpiness: Quarterly revenue swings wildly: Q2 2025 surged 111.5% YoY to $154.5M, but Q1 2026 grew only 4.9% to $76.7M. This lumpiness makes earnings unpredictable and complicates valuation, as seen in the negative EBITDA in Q3 2025.
- Russian contract expiration risk: A key risk is the expiration of a contract with Russia, a major supplier of enriched uranium. This could disrupt supply and hurt margins if replacement costs are higher. The company's reliance on Russian imports for a portion of its LEU is a geopolitical overhang.
- Negative free cash flow and high debt: TTM free cash flow is -$61.4 million, indicating cash burn. Debt-to-equity is 1.59, and interest expense was $4 million in Q1 2026. The company is investing heavily in HALEU production, which pressures cash flow and increases financial risk.
LEU Technical Analysis
Centrus Energy has been in a pronounced downtrend over the past year, with the stock price declining 16.05% over the last 12 months, significantly underperforming the S&P 500's gain of 18.56% over the same period. The current price of $175.78 sits at approximately 11.5% above the 52-week low of $142.13 but remains 62.1% below the 52-week high of $464.25, indicating that the stock is trading in the lower quartile of its 52-week range. This positioning suggests that the market has priced in significant pessimism, but the stock could still be a falling knife if the fundamental challenges persist.
Beta
1.33
1.33x market volatility
Max Drawdown
-66.4%
Largest decline past year
52-Week Range
$142-$464
Price range past year
Annual Return
-12.6%
Cumulative gain past year
| Period | LEU Return | S&P 500 |
|---|---|---|
| 1m | -7.3% | +0.1% |
| 3m | +7.5% | +4.4% |
| 6m | -7.9% | +14.6% |
| 1y | -12.6% | +18.6% |
| ytd | -36.2% | +12.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
LEU Fundamental Analysis
Centrus Energy's revenue trajectory has been volatile, with the most recent quarter (Q1 2026) showing revenue of $76.7 million, a 4.92% year-over-year increase from $73.1 million in Q1 2025. However, this growth is a sharp deceleration from the 111.5% surge in Q2 2025 (revenue of $154.5 million) and the 111.5% jump in Q4 2024 (revenue of $151.6 million), indicating that the company's top line is highly lumpy and dependent on contract timing. The LEU segment, which includes separative work units (SWU) and uranium, remains the primary revenue driver, with SWU sales of $41.6 million and uranium sales of $3.0 million in the latest quarter, while the Technical Solutions segment contributed $32.1 million in service revenue.
Quarterly Revenue
$76700000.0B
2026-03
Revenue YoY Growth
+4.9%
YoY Comparison
Gross Margin
38.7%
Latest Quarter
Free Cash Flow
$-61400000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is LEU Overvalued?
Given that Centrus Energy is profitable, with a trailing twelve-month net income of $10 million, the most appropriate valuation metric is the price-to-earnings (PE) ratio. The trailing PE stands at 56.06x, while the forward PE is 45.98x, implying that the market expects earnings growth of approximately 18% over the next year. This forward discount suggests that analysts anticipate continued profitability improvements, but the absolute multiples are elevated, reflecting the market's pricing of future growth rather than current earnings power.
PE
56.1x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 1x~28x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
33.0x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are significant. The company has a debt-to-equity ratio of 1.59, and interest expense of $4 million in Q1 2026, which consumes a large portion of operating income. Free cash flow is deeply negative at -$61.4 million TTM, indicating that the company is burning cash to fund HALEU expansion. Revenue is highly volatile, with quarterly swings from $57.7 million to $189 million, making earnings unpredictable. The company's profitability is thin, with a net margin of 17.3% TTM, but this is heavily dependent on contract timing and may not be sustainable. Additionally, the company's reliance on a few large contracts (e.g., the $900 million government contract) creates concentration risk.
FAQ
The key risks are: 1) Execution risk: HALEU production scale-up may face delays or technical issues, impacting revenue and cash flow. 2) Financial risk: The company has a debt-to-equity ratio of 1.59 and negative free cash flow of -$61.4 million, which could lead to dilution if capital is needed. 3) Geopolitical risk: The expiration of the Russian contract could disrupt supply and increase costs. 4) Valuation risk: The stock trades at a high PE, so any disappointment could lead to a sharp de-rating. The most severe risk is a combination of these factors, which could drive the stock down to the 52-week low of $142.13 or lower.
The 12-month forecast is uncertain, with a wide range of outcomes. In the bull case (30% probability), the stock could reach $250-$340, driven by successful HALEU commercialization and strong demand. In the base case (45% probability), the stock could trade around $200-$250, reflecting moderate growth and execution. In the bear case (25% probability), the stock could fall to $140-$180, due to execution failures or market headwinds. The most likely scenario is the base case, with the stock moving towards the analyst average target of $253.25, but volatility will be high. Key assumptions include continued demand for nuclear fuel and successful execution of the backlog.
LEU is overvalued relative to its current earnings, with a trailing PE of 56x and a forward PE of 46x, which are well above the market average. The PEG ratio is negative due to volatile earnings, indicating that the market is pricing in significant future growth. Compared to its own history, the stock is trading in the lower quartile of its 52-week range, but the valuation multiples are still elevated. The market is expecting the company to grow earnings by about 18% next year, which is plausible given the backlog, but if growth disappoints, the multiple could contract sharply. Overall, the stock is not cheap, but it may be fairly valued if HALEU commercialization succeeds.
LEU is a high-risk, high-reward stock. The analyst consensus is a Buy with an average target of $253.25, implying 44% upside from the current price of $175.78. However, the stock trades at a trailing PE of 56x, which is expensive, and the company has negative free cash flow. The biggest downside risk is a failure to scale HALEU production, which could lead to a decline to the 52-week low of $142.13, a 19% loss. For investors with a high risk tolerance and a long-term horizon, LEU could be a good buy, but it is not suitable for conservative investors. A better entry point would be below $150, providing a larger margin of safety.
LEU is more suitable for long-term investment due to its high volatility and the long-term nature of its growth story. The stock has a beta of 1.35, and its price has swung from $142 to $464 in the past year, making it risky for short-term trading. The company is in an investment phase, with negative free cash flow, and the payoff from HALEU production is expected over several years. For long-term investors, a minimum holding period of 3-5 years is recommended to allow the company to execute on its backlog and achieve profitability. Short-term traders may find opportunities, but they must be prepared for significant price swings. The company pays no dividend, so returns depend entirely on capital appreciation.
